Skip to content

Physiotherapy in the Haemophilic Arthropathy of the Elbow.

Physiotherapy in the Treatment of Elbow Hemophilic Arthropathy: Manual Therapy vs Educational Physiotherapy. A Pilot Sudy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02198040
Acronym
ELBOW
Enrollment
27
Registered
2014-07-23
Start date
2012-01-31
Completion date
2014-06-30
Last updated
2018-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Hemophilia

Keywords

Elbow, Joint disease, Hemophilia, Physiotherapy modalities

Brief summary

The aim of this study is to assess the effectiveness of two treatments of Physiotherapy: one with joint traction, passive muscles stretching and Proprioceptive Neuromuscular Facilitation (PNF), and the other with education sessions and home exercises, for the improvement of the ROM, biceps strength, perimeter of arm and the perception of pain in PwH and arthropathy of the elbow.

Detailed description

The intervention was carried out during twelve weeks, performing evaluations before and after treatment, and six months of finalizing this. The treatment of MT group consisted of two sessions per week, one hour each, and the treatment of group E consisted in a session for 90 minutes every two weeks, with daily home exercises. The control group (group C) did not receive any intervention.

Interventions

OTHERManual Therapy

* 5 minutes. Termotherapy shalow to 50 cm away from the elbow, using a bulb of 250w. * 15 minutes. Joint traction of elbow, in submaximal mobility amplitude with distal fixation of humerus and proximal fixation of radius and ulna in neutral position of forearm. Joint traction in I-II degree of flexion and extension submaximal of elbow. * 15 minutes. Passive muscle stretching (within the limits of mobility). * 15 minutes. Proprioceptive neuromuscular facilitation (PNF) of upper limb, from the abduction, flexion and external rotation of shoulder. * 10 minutes. Local cryotherapy with ice bag and protection between it and the skin

* Theory: Introduction to hemophilia: clinic and treatment; Anatomy and biomechanics of elbow; Anatomy of elbow musculature. Function of muscles and haematomas treatment; Haemarthrosis, synovitis and arthropathy: clinical manifestations and treatment; Proprioception: definition and importance in hemophilia; and Physical activity and sport: risks and benefits. * Practice: exercises in favor of gravity; isometric and isotonic exercises of elbow; active exercises for mobility and pain management; elbow proprioception exercises; and swimming technique.

Sponsors

Universidad Católica San Antonio de Murcia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years * Patients diagnosed with hemophilia A or B * Patients with hemophilic arthropathy in one or both elbows

Exclusion criteria

* Patients with another medical diagnosis (eg, Von Willebrand's disease) * Patients with presence of antibodies to FVIII or FIX (inhibitors) * Patients who had a haemarthrosis of elbow during the study

Design outcomes

Primary

MeasureTime frameDescription
Changes in the Circumference of ArmScreening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)Measurement of the arm circumference (in cm) at baseline as a result of hemophilic arthropathy and after treatment and follow-up. The measurement in the upper third of the arm, in the middle of the triceps muscle belly, with a tape measure. We use this outcome to measure circumference of the arm, it is the most clinical measurement used by physiotherapists.
Changes in the Pain Perception of ElbowScreening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)Using the visual analogue scale, VAS (subjective rating scale with a score from 0 to 10, where 0 indicates no pain and 10 the maximum pain imaginable by the patient).
Assessment of Radiological Joint DeteriorationScreening visit (pretreatment assessment)Pettersson scale is an additive scale that assesses the radiological joint damage in patients with hemophilic arthropathy. It is scored as a range of 0-13 points (0: no joint damage; 13: maximum joint damage). This scale assesses: osteoporosis, widened epiphyseal, irregularity of the chondral surface, joint space narrowing, subchondral cyst formation, joint margins erosion, joint incongruence and joint deformity (angulation and displacement)
Changes in Range of Motion of ElbowScreening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)Measurement the changes of flexion and extension of elbow (in degrees) using a universal goniometer. We were taken as anatomical references, those specified by Querol et al, using the zero-method-reference for the mobile arm goniometer as indicated Norkin et al.
Changes in Biceps StrengthScreening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)Measured by the breaking test for patients with haemophilia with a score from 0 to 5 (where 0 indicates normal strength and 5 is the absence of muscle contraction).

Secondary

MeasureTime frameDescription
Frequency of Elbow HemarthrosisScreening visit (pretreatment assessment)Number of elbow hemarthrosis in the month prior to study
Characteristics of the PatientsScreening visit (pretreatment assessment)Age of patients included in teh study (years)

Countries

Spain

Participant flow

Recruitment details

27 patients Hemophilia of the Association of Murcia were recruited between January to October 2013

Pre-assignment details

28 patients who met the exclusion criteria. Only one declined to participate for personal reasons.

Participants by arm

ArmCount
Manual Therapy Group
The treatment of this group consisted of two sessions per week, one hour each. Manual Therapy: - 5 minutes. Termotherapy shalow to 50 cm away from the elbow, using a bulb of 250w. * 15 minutes. Joint traction of elbow, in submaximal mobility amplitude with distal fixation of humerus and proximal fixation of radius and ulna in neutral position of forearm. Joint traction in I-II degree of flexion and extension submaximal of elbow. * 15 minutes. Passive muscle stretching (within the limits of mobility). Compression technique, passive muscle stretching and relaxation in biceps and triceps. * 15 minutes. Proprioceptive neuromuscular facilitation (PNF) of upper limb, from the abduction, flexion and external rotation of shoulder with extension of elbow and dorsal flexion of wrist, to adduction, internal rotation of shoulder with flexion of elbow and palmar flexion of wrist and fingers. * 10 minutes. Local cryotherapy with ice bag and protection between it and the skin
9
Educational Gruop
The treatment had education and home daily exercises for the improvement of the range of motion, biceps strength, perimeter of arm and the perception of pain in patients with haemophilia and arthropathy of the elbow. Educational group: - Theory: Introduction to hemophilia: clinic and treatment; Anatomy and biomechanics of elbow; Anatomy of elbow musculature. Function of muscles and haematomas treatment; Haemarthrosis, synovitis and arthropathy: clinical manifestations and treatment; Proprioception: definition and importance in hemophilia; and Physical activity and sport: risks and benefits. \- Practice: exercises in favor of gravity; isometric and isotonic exercises of elbow; active exercises for mobility and pain management; elbow proprioception exercises; and swimming technique.
9
Control Group
The control group did not receive any intervention. The patients in this group were assessed by the same reviewers (blinded to the study conditions) and under the same conditions, that patients in the experimental groups.
9
Total27

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyWithdrawal by Subject001
Overall StudyWork reasons010

Baseline characteristics

CharacteristicManual Therapy GroupEducational GruopControl GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants9 Participants9 Participants27 Participants
Radiological joint deterioration9.63 units on a scale
STANDARD_DEVIATION 1.62
8.50 units on a scale
STANDARD_DEVIATION 3.4
7.57 units on a scale
STANDARD_DEVIATION 2.9
8.61 units on a scale
STANDARD_DEVIATION 2.809
Region of Enrollment
Spain
9 participants9 participants9 participants27 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
9 Participants9 Participants9 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 90 / 90 / 9
serious
Total, serious adverse events
0 / 90 / 90 / 9

Outcome results

Primary

Assessment of Radiological Joint Deterioration

Pettersson scale is an additive scale that assesses the radiological joint damage in patients with hemophilic arthropathy. It is scored as a range of 0-13 points (0: no joint damage; 13: maximum joint damage). This scale assesses: osteoporosis, widened epiphyseal, irregularity of the chondral surface, joint space narrowing, subchondral cyst formation, joint margins erosion, joint incongruence and joint deformity (angulation and displacement)

Time frame: Screening visit (pretreatment assessment)

Population: It has made an analysis by intention to treat with the 27 patients included in the study. It has been estimated the radiological joint damage means (and standard deviation) for elbow joint.

ArmMeasureValue (MEAN)Dispersion
Educational GruopAssessment of Radiological Joint Deterioration9.63 pointsStandard Deviation 1.62
Manual Therapy GroupAssessment of Radiological Joint Deterioration8.50 pointsStandard Deviation 3.4
Control GroupAssessment of Radiological Joint Deterioration7.57 pointsStandard Deviation 2.9
Primary

Changes in Biceps Strength

Measured by the breaking test for patients with haemophilia with a score from 0 to 5 (where 0 indicates normal strength and 5 is the absence of muscle contraction).

Time frame: Screening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)

Population: It has made an analysis by intention to treat with the 27 patients included in the study

ArmMeasureGroupValue (MEAN)Dispersion
Educational GruopChanges in Biceps StrengthPostreatment assessment0.03 pointsStandard Deviation 0.12
Educational GruopChanges in Biceps StrengthPretreatment assessment0.000 pointsStandard Deviation 0
Educational GruopChanges in Biceps StrengthFollow up assessment0.06 pointsStandard Deviation 0.17
Manual Therapy GroupChanges in Biceps StrengthPostreatment assessment0.00 pointsStandard Deviation 0
Manual Therapy GroupChanges in Biceps StrengthPretreatment assessment0.094 pointsStandard Deviation 0.272
Manual Therapy GroupChanges in Biceps StrengthFollow up assessment0.00 pointsStandard Deviation 0
Control GroupChanges in Biceps StrengthPretreatment assessment0.143 pointsStandard Deviation 0.363
Control GroupChanges in Biceps StrengthFollow up assessment0.07 pointsStandard Deviation 0.18
Control GroupChanges in Biceps StrengthPostreatment assessment0.07 pointsStandard Deviation 0.18
Primary

Changes in Range of Motion of Elbow

Measurement the changes of flexion and extension of elbow (in degrees) using a universal goniometer. We were taken as anatomical references, those specified by Querol et al, using the zero-method-reference for the mobile arm goniometer as indicated Norkin et al.

Time frame: Screening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)

Population: It has made an analysis by intention to treat with the 27 patients included in the study.

ArmMeasureGroupValue (MEAN)Dispersion
Educational GruopChanges in Range of Motion of ElbowPostreatment assessment135.56 degreesStandard Deviation 16.66
Educational GruopChanges in Range of Motion of ElbowPretreatment assessment138.31 degreesStandard Deviation 16.103
Educational GruopChanges in Range of Motion of ElbowFollow up assessment139.19 degreesStandard Deviation 16.64
Manual Therapy GroupChanges in Range of Motion of ElbowPostreatment assessment140.31 degreesStandard Deviation 11.24
Manual Therapy GroupChanges in Range of Motion of ElbowPretreatment assessment136.13 degreesStandard Deviation 14.818
Manual Therapy GroupChanges in Range of Motion of ElbowFollow up assessment140.31 degreesStandard Deviation 14.44
Control GroupChanges in Range of Motion of ElbowPretreatment assessment138.00 degreesStandard Deviation 19.958
Control GroupChanges in Range of Motion of ElbowFollow up assessment138.07 degreesStandard Deviation 17.39
Control GroupChanges in Range of Motion of ElbowPostreatment assessment138.43 degreesStandard Deviation 18.47
Primary

Changes in the Circumference of Arm

Measurement of the arm circumference (in cm) at baseline as a result of hemophilic arthropathy and after treatment and follow-up. The measurement in the upper third of the arm, in the middle of the triceps muscle belly, with a tape measure. We use this outcome to measure circumference of the arm, it is the most clinical measurement used by physiotherapists.

Time frame: Screening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)

Population: It has made an analysis by intention to treat with the 27 patients included in the study

ArmMeasureGroupValue (MEAN)Dispersion
Educational GruopChanges in the Circumference of ArmPostreatment assessment31.23 cmStandard Deviation 3.22
Educational GruopChanges in the Circumference of ArmPretreatment assessment31.125 cmStandard Deviation 3.144
Educational GruopChanges in the Circumference of ArmFollow up assessment31.02 cmStandard Deviation 3.13
Manual Therapy GroupChanges in the Circumference of ArmPostreatment assessment31.72 cmStandard Deviation 3.2
Manual Therapy GroupChanges in the Circumference of ArmPretreatment assessment31.331 cmStandard Deviation 3.474
Manual Therapy GroupChanges in the Circumference of ArmFollow up assessment30.96 cmStandard Deviation 2.7
Control GroupChanges in the Circumference of ArmPretreatment assessment32.007 cmStandard Deviation 3.837
Control GroupChanges in the Circumference of ArmFollow up assessment31.68 cmStandard Deviation 4.11
Control GroupChanges in the Circumference of ArmPostreatment assessment31.85 cmStandard Deviation 3.56
Primary

Changes in the Pain Perception of Elbow

Using the visual analogue scale, VAS (subjective rating scale with a score from 0 to 10, where 0 indicates no pain and 10 the maximum pain imaginable by the patient).

Time frame: Screening visit (pretreatment assessment), postreatment evaluation (12 week) and follow up assessment (6 months after treatment)

ArmMeasureGroupValue (MEAN)Dispersion
Educational GruopChanges in the Pain Perception of ElbowPostreatment assessment0.09 pointsStandard Deviation 0.2
Educational GruopChanges in the Pain Perception of ElbowPretreatment assessment0.156 pointsStandard Deviation 0.301
Educational GruopChanges in the Pain Perception of ElbowFollow up assessment0.18 pointsStandard Deviation 0.35
Manual Therapy GroupChanges in the Pain Perception of ElbowPostreatment assessment0.34 pointsStandard Deviation 0.43
Manual Therapy GroupChanges in the Pain Perception of ElbowPretreatment assessment0.719 pointsStandard Deviation 0.752
Manual Therapy GroupChanges in the Pain Perception of ElbowFollow up assessment0.12 pointsStandard Deviation 0.28
Control GroupChanges in the Pain Perception of ElbowPretreatment assessment0.143 pointsStandard Deviation 0.305
Control GroupChanges in the Pain Perception of ElbowFollow up assessment0.10 pointsStandard Deviation 0.28
Control GroupChanges in the Pain Perception of ElbowPostreatment assessment0.07 pointsStandard Deviation 0.67
Secondary

Characteristics of the Patients

Age of patients included in teh study (years)

Time frame: Screening visit (pretreatment assessment)

ArmMeasureValue (MEAN)Dispersion
Educational GruopCharacteristics of the Patients33.78 yearsStandard Deviation 15.72
Manual Therapy GroupCharacteristics of the Patients32.33 yearsStandard Deviation 11.67
Control GroupCharacteristics of the Patients37.33 yearsStandard Deviation 12.26
Secondary

Frequency of Elbow Hemarthrosis

Number of elbow hemarthrosis in the month prior to study

Time frame: Screening visit (pretreatment assessment)

ArmMeasureGroupValue (MEAN)Dispersion
Educational GruopFrequency of Elbow HemarthrosisHemarthros the month before the beginning of the s1.06 bleeding eventsStandard Deviation 1.23
Educational GruopFrequency of Elbow HemarthrosisHemarthros during the study0.00 bleeding eventsStandard Deviation 0
Manual Therapy GroupFrequency of Elbow HemarthrosisHemarthros the month before the beginning of the s1.06 bleeding eventsStandard Deviation 0.68
Manual Therapy GroupFrequency of Elbow HemarthrosisHemarthros during the study0.00 bleeding eventsStandard Deviation 0
Control GroupFrequency of Elbow HemarthrosisHemarthros the month before the beginning of the s0.71 bleeding eventsStandard Deviation 0.91
Control GroupFrequency of Elbow HemarthrosisHemarthros during the study0.62 bleeding eventsStandard Deviation 0.87

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026